Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Feb;33(2):187–189. doi: 10.1111/j.1365-2125.1992.tb04023.x

The distribution of cis- and trans-acitretin in human epidermis.

E Meyer 1, W Lambert 1, A De Leenheer 1, J De Bersaques 1, A Kint 1
PMCID: PMC1381306  PMID: 1532322

Abstract

The concentrations of trans-acitretin and its principal metabolite, cis-acitretin, were measured by h.p.l.c. after single and multiple dosing (50 mg orally for 13 days) in plasma, blister fluid and epidermal samples from four healthy male volunteers. Within-day epidermal concentrations of trans-acitretin exceeded those of the cis-form which were at the limit of assay sensitivity. No accumulation of trans-acitretin was observed in plasma or blister fluid but AUC values for the drug in blister roof cells tended to be higher after multiple dosing.

Full text

PDF
187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brindley C. J. Overview of recent clinical pharmacokinetic studies with acitretin (Ro 10-1670, etretin). Dermatologica. 1989;178(2):79–87. doi: 10.1159/000248397. [DOI] [PubMed] [Google Scholar]
  2. De Leenheer A. P., Lambert W. E., De Bersaques J. P., Kint A. H. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma. J Chromatogr. 1990 Feb 2;500:637–642. doi: 10.1016/s0021-9673(00)96098-9. [DOI] [PubMed] [Google Scholar]
  3. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol. 1968 Feb;50(2):129–137. doi: 10.1038/jid.1968.15. [DOI] [PubMed] [Google Scholar]
  4. Laugier J. P., Berbis P., Brindley C., Bun H., Geiger J. M., Privat Y., Durand A. Determination of acitretin and 13-cis-acitretin in skin. Skin Pharmacol. 1989;2(4):181–186. [PubMed] [Google Scholar]
  5. Massarella J., Vane F., Buggé C., Rodriguez L., Cunningham W. J., Franz T., Colburn W. Etretinate kinetics during chronic dosing in severe psoriasis. Clin Pharmacol Ther. 1985 Apr;37(4):439–446. doi: 10.1038/clpt.1985.68. [DOI] [PubMed] [Google Scholar]
  6. Meyer E., Lambert W. E., De Leenheer A. P., Bersaques J. P., Kint A. H. Improved quantitation of 13-cis- and all-trans-acitretin in human plasma by normal-phase high-performance liquid chromatography. J Chromatogr. 1991 Sep 18;570(1):149–156. doi: 10.1016/0378-4347(91)80209-u. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES